Family study of genetic and environmental factors determining the protein binding of propranolol
- 1 January 1983
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 25 (4) , 437-441
- https://doi.org/10.1007/bf00542107
Abstract
The unbound fraction of propranolol was found to vary from 1.9 to 13.2% in 434 plasma samples from members of 132 families. As expected, there was a linear correlation between the ratio of bound/unbound propranolol and the orosomucoid concentration (r=0.67, P<0.001). Albumin concentration did not influence propranolol binding. The unbound fraction was negatively correlated with obesity and alcohol intake, but was not significantly influenced by age and sex. By applying path analysis, 21% of the variability in propranolol binding could be ascribed to genetic factors and 5% to common environmental factors.Keywords
This publication has 24 references indexed in Scilit:
- Protein binding of ampicillin. Path analysis of a twin materialHereditas, 2009
- Cultural and biological determinants of lipoprotein concentrationsAnnals of Human Genetics, 1979
- Behavioral, social, and physiological determinants of lipoprotein concentrationsSocial Biology, 1977
- Protein binding of drugs in uremic and normal serum: The role of endogenous binding inhibitorsBiochemical Pharmacology, 1976
- Microultrafiltration Technique for Drug-Protein Binding Determination in PlasmaJournal of Pharmaceutical Sciences, 1974
- Interindividual differences in plasma protein binding of nortriptyline in man ? A twin studyEuropean Journal of Clinical Pharmacology, 1972
- Electroimmuno AssayScandinavian Journal of Clinical and Laboratory Investigation, 1972
- Inheritance of human α1-acid glycoprotein (orosomucoid) variantsJournal of Clinical Investigation, 1969
- Serum Proteins in Finnish TwinsHuman Heredity, 1968
- Serum Glycoproteins in Monozygotic and Dizygotic Twins.Experimental Biology and Medicine, 1958